Founder · Pharma + AI + Quantum

Heinz
Jungbluth

Pharmaceutical scientist, full-stack CTO, and quantum drug discovery architect.

I build at the intersection of life sciences, business operations, and frontier compute. Founder of Molevera (BioQL quantum drug discovery on IBM 156-qubit hardware), Bionics-AI (natural therapeutics pipeline), and Vibe Studio AI (fractional CTO studio). Former Country Manager at Eurofins Scientific LATAM, co-founder of a cannabis QC laboratory in Denver and Lima, and 15+ years operating regulated industries.

0
Active ventures
0
IBM quantum HW
0
Docking runs
0
Years experience
Heinz Jungbluth
The story

A pharmaceutical chemist who taught himself quantum computing.

I started as a pharmaceutical chemist selling and commissioning chromatography systems — HPLC, GC-MS — at Kossodo SAC in Lima for pharma, food, and environmental clients. I learned the analytical stack from the instrument up.

From there I moved into cannabis quality controlco-founding Altitude Lab Solutions, a specialized cannabis testing laboratory with offices in Denver, Colorado and Lima, Peru, providing analytical testing for potency, pesticides, heavy metals, microbiology, and terpene profiling. In parallel I founded Greentech Solutions, a LATAM cannabis consulting firm advising operators on cultivation, licensing, and go-to-market strategy.

In 2021 I joined Eurofins Scientific — the world's largest quality control laboratory network — as Country Manager for Peru with full P&L responsibility across multiple service divisions. I spearheaded Eurofins' cannabis testing business across Latin America including Colombia, drove M&A target identification, and built strategic relationships with producers, regulators, and investors across the region.

In 2024 I went all-in on the most exciting bet of my life: teaching myself Python, machine learning, and quantum computing from scratch, then building a quantum-native drug discovery platform on IBM 156-qubit hardware. Today I run three companies — Molevera (BioQL), Bionics-AI, and Vibe Studio AI — all applying the same combination: pharma domain expertise, operator instinct, and frontier compute.

The combination founders actually need is rare: production AI/ML engineering, regulated-industry instinct, and a P&L operator's view of what ships and what doesn't.

Currently building

Three ventures, one operator.

Each company solves a different layer of the same problem: how to bring the latest computational science to real drug discovery and biotech execution.

Stealth · 2024+

Molevera

BioQL — Quantum-Native Drug Discovery
Founder & CEO · sole technical architect

Molevera's BioQL is a quantum-native drug discovery platform running on IBM Boston 156-qubit (Heron R3) hardware. The first commercial pipeline that gives pharma R&D teams quantum chemistry as an API call — no quantum PhDs required.

  • VQE / UCCSD molecular energetics on real quantum hardware
  • QAOA optimization for lead discovery & scaffold hopping
  • 4-layer error mitigation: ZNE, M3, Dynamical Decoupling, Pauli Twirling
  • End-to-end ADMET → IND-ready compound dossiers (FDA-aligned)
  • Validated programs: TSPO/ALS, KRAS G12C, HER2, Alzheimer's
molevera.com See TSPO demo
Operating · 2025+

Bionics-AI

AI-Driven Natural Therapeutics
Founder & CEO · full-stack architect

Integrated AI drug discovery platform with 7 specialized modules and 50+ AI models for end-to-end discovery. Focused on natural therapeutics from 500,000+ unexplored Andes-Amazon-Asia compounds.

  • Bionics-GENOME · GENOX · InSilicoX · MedOX · PHARMOX · RiboX · VizDOck
  • Stack: ESM3, Bio-HNET, Boltz-2, Chai-1, DiffDock, FlashMD, AlphaFold
  • LLMs: MPT-7B, TxGemma (2B-27B), Precious3-GPT
  • Infrastructure: Modal A100/H100 serverless GPU compute
  • 220+ docking runs · 95% cost reduction · 8h time-to-result
  • GLP-1R berberine derivatives · Oxylipin-JG IL-17 platform
  • Eurofins Discovery validation partnership formalized
Investor relations
Active · 2026+

Vibe Studio AI

Fractional CTO + Senior AI Engineering
Founder & CEO · Austin, TX

Fractional CTO and senior AI engineering studio for funded startups, biotech, and pharma. Founder-level delivery without the cost or risk of a $300K+ full-time CTO hire.

  • AI Tech Audit — $1,500 fixed, 7 days
  • 4-Week AI Sprint — $8,500 fixed, production output
  • Fractional CTO Retainer — $5,000/mo, 3-mo minimum
  • Specialty: biotech, pharma, regulated AI, quantum-for-pharma
  • 24h proposal turnaround · SOC2-aware · weekly demos
  • Real clients ship real code — not slide decks
vibestudio.tech
Live Case Study · BioQL Platform

TSPO-001 · ALS Neuroinflammation Lead Compound

Quantum-accelerated drug discovery on IBM 156Q

Target: TSPO (Translocator Protein 18kDa), primary PET imaging target for neuroinflammation in Amyotrophic Lateral Sclerosis (ALS). Structure from PDB 8E7Z with druggability score 0.95.

BioQL executed a complete in silico pipeline on IBM Boston 156-qubit quantum hardware — 10 quantum compute jobs in 30.5 minutes — generating and evaluating 5 candidate molecules (all passing Lipinski Rule of Five).

0.676
Composite Score
-10.89
kcal/mol binding
52.4%
Bioavailability
0.95
Druggability
40.3%
Approval prob.

Every quantum computation executed on a real 156-qubit superconducting processor with 4 layers of error mitigation (ZNE, M3, Dynamical Decoupling, Pauli Twirling) for publication-grade accuracy.

Download full report (15 pages)
TSPO-001 lead compound docked in protein pocket TSPO-001 binding pocket surface view TSPO candidate 2 docked TSPO candidate 2 surface

Real PyMOL renders of TSPO-001 candidates docked in PDB 8E7Z binding pocket · publication-grade

Cannabis Industry

A decade inside regulated cannabis operations.

Before quantum computing, before AI drug discovery, there was cannabis. Six years co-founding labs, consulting operators, and running the LATAM cannabis QC business at Eurofins. Deep scars, deep knowledge.

Altitude Lab Solutions

CO-FOUNDER · Denver, CO + Lima, Peru

Co-founded a specialized cannabis QC laboratory with offices in Denver, Colorado and Lima, Peru. Analytical testing for cannabis and hemp products: potency, pesticides, heavy metals, microbiology, terpene profiling. Legal representative and strategic lead across both jurisdictions.

Greentech Solutions Consulting

FOUNDER & OWNER · Lima, Peru

Founded a LATAM cannabis consulting firm advising producers, investors, and distributors on cultivation development, farm design, licensing strategy, analytical method development, and full business setup for regulated markets.

Eurofins LATAM Cannabis Business

COUNTRY MANAGER · Peru + Colombia

Spearheaded Eurofins' cannabis quality testing business across Latin America including key operations in Colombia — regulatory compliance, laboratory partnerships, client acquisition, and positioning Eurofins as the reference cannabis QC laboratory for emerging LATAM markets.

Analytical Method Development

HANDS-ON · 6+ years

Developed and validated analytical techniques for cannabis quality assessment: potency (HPLC), terpene profiling (GC-MS), residual pesticides (LC-MS/MS), heavy metals (ICP-MS), microbiology. Know the lab floor, not just the spreadsheet.

LATAM Producer Network

BUSINESS DEVELOPMENT · Colombia · Uruguay · Brazil · Mexico · Peru

Built and sustained strategic relationships with cannabis producers, distributors, and regulators across LATAM. First-hand knowledge of the regulatory and commercial landscape of each market.

Regulatory Navigation

COMPLIANCE · Multi-jurisdiction

Managed compliance across Colorado state cannabis testing requirements, LATAM emerging frameworks, EU-GMP pathway considerations, and international sample logistics with chain-of-custody integrity across multiple jurisdictions.

Selected outcomes

Numbers that matter.

A handful of milestones from across the three ventures and past roles.

156
Qubits on IBM hardware (Heron R3) running BioQL
220+
Molecular docking runs executed at Bionics-AI
7
Specialized AI modules built in Bionics-AI platform
50+
AI models integrated (ESM3, Boltz-2, TxGemma...)
95%
Cost reduction vs traditional drug discovery
8h
Time-to-result per compound (vs 72h industry)
3
Active companies founded simultaneously
4,687
Pharmaceutical targets in Bionics-AI database
Experience

A non-linear path that compounds.

From chromatography instrument sales to quantum drug discovery — each stop deliberately added a layer.

JUL 2024 — PRESENT
Founder & CEO · Molevera
BioQL quantum-native drug discovery · Boston, USA · molevera.com

Sole technical architect and CEO. Designed and implemented molecular energy calculation pipelines using VQE, UCCSD, QAOA, and Grover Search algorithms on IBM 156-qubit quantum hardware, targeting clinically validated drug targets in oncology, neurology, and ALS neuroinflammation. Developed end-to-end compound dossiers from quantum docking and ADMET profiling to IND-ready regulatory documents. Managing technical roadmap, cloud infrastructure, and LLM fine-tuning pipelines (Qwen2.5-7B on Modal A100s). Validated programs: TSPO-001 (ALS), KRAS G12C, HER2, Alzheimer's dual-inhibitor.

JAN 2025 — PRESENT
Founder & CEO · Bionics-AI
AI drug discovery platform · Boston, USA

Built a 7-module integrated AI drug discovery platform (Bionics-GENOME, GENOX, InSilicoX, MedOX, PHARMOX, RiboX, VizDOck) orchestrating 50+ AI models on Modal GPUs (ESM3, Bio-HNET, Boltz-2, Chai-1, DiffDock, FlashMD, AlphaFold, TxGemma). Executed 220+ docking runs in seven months, identified novel GLP-1R modulators from berberine derivatives, discovered Oxylipin-JG (from Jergón Sacha) with selective IL-17 axis modulation. Formalized Eurofins Discovery validation partnership. 95% cost reduction and 9x time improvement vs industry benchmarks.

MAR 2021 — JUL 2024
Country Manager
Eurofins Scientific · Lima · LATAM

Led all Eurofins Peru business lines with full P&L responsibility across multiple analytical service divisions (pharma, food, environment, cannabis). Spearheaded Eurofins' cannabis quality testing business across Latin America including key operations in Colombia. Built strategic relationships with cannabis producers, distributors, and regulators across LATAM, positioning Eurofins as the reference cannabis QC laboratory. Drove M&A target identification and acquisition to expand Eurofins' footprint across the region. Coordinated international sample logistics with chain-of-custody integrity across multiple jurisdictions.

OCT 2019 — MAR 2021
Co-Founder & General Manager
Altitude Lab Solutions SAC · Denver, CO + Lima, Peru

Co-founded a specialized cannabis quality control laboratory with offices in Denver, Colorado and Lima, Peru, providing analytical testing for cannabis and hemp products including potency, pesticides, heavy metals, microbiology, and terpene profiling. Managed regulatory compliance across multiple jurisdictions ensuring laboratory operations met Colorado state cannabis testing requirements and international standards. Served as legal representative and strategic leader.

OCT 2018 — MAR 2021
Founder & Owner
Greentech Solutions Consulting SAC · Lima, Peru

Founded and managed a specialized consulting firm focused on the LATAM cannabis industry — advising clients on cultivation development, farm design, licensing strategy, and full business setup for cannabis operations. Provided end-to-end consulting including facility planning, strain selection, agronomic protocols, regulatory compliance, and go-to-market strategy. Developed and validated analytical techniques for cannabis quality assessment.

SEP 2012 — OCT 2018
Head of Chromatography Business Unit
Kossodo SAC · Lima, Peru

Led the chromatography business unit for six years, managing key corporate accounts across pharma, food, and environmental industries. Oversaw installation, commissioning, and training for advanced chromatographic (HPLC, UHPLC) and mass-spectrometry (GC-MS, LC-MS/MS) instruments. Developed customized analytical methods meeting clients' regulatory and quality standards across Peru.

Expertise

Where pharma, code, and business meet.

A combined skill set that's unusual in the market — built deliberately across lab bench, IDE, boardroom, and cloud. This is why I get hired as fractional CTO AND business advisor.

Quantum Computing for Drug Discovery

VQE, UCCSD, QAOA, Grover Search on IBM 156-qubit hardware. Hybrid classical/quantum molecular energy calculations. Error mitigation: ZNE, M3, Dynamical Decoupling, Pauli Twirling.

IBM QuantumQiskitVQEQAOA

AI / ML for Life Sciences

Production AI/ML pipelines for drug discovery. Protein structure prediction, molecular docking, binding affinity, ADMET. LLM fine-tuning on domain data.

ESM3Bio-HNETBoltz-2DiffDockAlphaFoldChai-1

Full-Stack Python Engineering

Self-taught full-stack Python developer. From data pipelines to production APIs to cloud-native deployments. Built the entire Bionics-AI platform and BioQL pipeline solo.

PythonFastAPIModalDockerPyMOLRDKit

LLM Fine-Tuning & Deployment

Fine-tuning open-source LLMs (Qwen2.5-7B) on life-sciences domain data. LoRA/QLoRA, RAG architectures, tool use, agentic workflows. Deployed to Modal A100/H100 GPU infrastructure.

Qwen2.5MPT-7BTxGemmaLoRARAG

Fractional CTO

Fractional CTO engagements with biotech, SaaS, and deep-tech founders. Architecture decisions, AI/ML strategy, hiring, vendor evaluation, investor technical narrative, delivery oversight.

System DesignAI StrategyDDHiring

Business Operations & P&L

Country Manager experience at Eurofins (world's largest QC lab network) with full P&L responsibility. M&A target identification. Board-level technical narrative.

P&LM&AStrategic Partnerships

Pharmaceutical Sciences

B.Sc. Pharmaceutical Sciences & Biochemistry. Hands-on with HPLC, UHPLC, GC-MS, LC-MS/MS, ICP-MS. Analytical method development for regulated industries: pharma, food, cannabis, environmental.

HPLCGC-MSLC-MS/MSICP-MS

Cannabis Industry Expert

10+ years across cannabis QC labs (Denver + Lima co-founder), cannabis consulting (Greentech), and Eurofins LATAM cannabis testing. Regulatory, analytical, commercial, and operational expertise.

QC TestingLicensingLATAMRegulatory

Strategic Business Advisory

Advisor-level capacity for startups and SMEs navigating regulated industries, technical strategy, fundraising narrative, or go-to-market in LATAM. Rare combination of operator + technical depth.

AdvisoryStrategyFundraisingGTM
Education

Formal + self-directed.

B.Sc. Pharmaceutical Sciences & Biochemistry
Universidad Inca Garcilaso de la Vega · Lima, Peru
2005 — 2010

Plus continuous self-directed mastery in Python, machine learning, quantum computing, computational chemistry, cloud infrastructure, and LLM fine-tuning — the tools that turned a pharmaceutical chemist into the architect of Molevera (BioQL) and Bionics-AI.

Get in touch

Let's talk.

I'm open to: pharma partnerships for Molevera / BioQL · investor introductions for Bionics-AI · fractional CTO engagements through Vibe Studio AI · technical due diligence for VCs · strategic advisory for biotech / regulated-industry founders.